- Description
- Table of Contents
- Request Sample
The Global Clinical Trials market is expected to reach $69.41 billion by 2026 growing at a CAGR of 7.8% during 2018 to 2026. A clinical trial is a type of research that studies a test or treatment given to people. Clinical trials study how safe and helpful tests and treatments are. When found to be safe and helpful, they may become tomorrow's standard of care. Some of the factors such as high R&D spending of the pharmaceutical industry and growing prevalence of disease and new disease cases are fuelling the market growth. However, lower healthcare reimbursement in the developing countries is restraining the market growth. Based on Application, Oncology segment has witnessed significant growth due to the rise in number of disease cases and innovative headways that guide exact recognizable proof of illness causing cases and technological advancements that aid precise identification of ailment-causing organisms. The key vendors mentioned are SGS SA, Wuxi AppTec Inc, QuintilesIMS, PRA Health Sciences, Pharmaceutical Product Development LLC, Parexel International Corporation, Novo Nordisk A/S, Laboratory Corporation Of America, INC Research, ICON Plc, Chiltern International Ltd and Charles River Laboratory. Study Designs Covered: • Expanded Access • Interventional • Observational Phases Covered: • Phase I • Phase II • Phase III • Phase IV Indications Covered: • Pain management • Ophthalmology • Oncology • Obesity • Nose • Musculoskeletal • Metabolic • Mental disorders • Infections • Genitourinary • Gastrointestinal • Ear • Diabetes • Dermatology • CVS • Congenital • CNS condition • Circulatory • Cardiovascular • Cancer • Blood disorders • Autoimmune End Users Covered: • Dental Academic • Dental Hospitals & Clinics • Dental Institutes • Research Institutes Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Clinical Trials Market, By Study Design
5.1 Introduction
5.2 Expanded Access
5.3 Interventional
5.4 Observational
6 Global Clinical Trials Market, By Phase
6.1 Introduction
6.2 Phase I
6.3 Phase II
6.4 Phase III
6.5 Phase IV
7 Global Clinical Trials Market, By Indication
7.1 Introduction
7.2 Pain management
7.3 Ophthalmology
7.4 Oncology
7.5 Obesity
7.6 Nose
7.7 Musculoskeletal
7.8 Metabolic
7.9 Mental disorders
7.10 Infections
7.11 Genitourinary
7.12 Gastrointestinal
7.13 Ear
7.14 Diabetes
7.15 Dermatology
7.16 CVS
7.17 Congenital
7.18 CNS condition
7.19 Circulatory
7.20 Cardiovascular
7.21 Cancer
7.22 Blood disorders
7.23 Autoimmune
8 Global Clinical Trials Market, By End User
8.1 Introduction
8.2 Dental Academic
8.3 Dental Hospitals & Clinics
8.4 Dental Institutes
8.5 Research Institutes
9 Global Clinical Trials Market, By Geography
7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 South America
7.5 Middle East & Africa
10 Strategic Benchmarking
11 Vendors Landscape
11.1 SGS SA
11.2 Wuxi AppTec Inc
11.3 QuintilesIMS
11.4 PRA Health Sciences
11.5 Pharmaceutical Product Development LLC
11.6 Parexel International Corporation
11.7 Novo Nordisk A/S
11.8 Laboratory Corporation Of America
11.9 INC Research
11.10 ICON Plc
11.11 Chiltern International Ltd
11.12 Charles River Laboratory
List of Data Tables
Table 1 Global Clinical Trials Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Clinical Trials Market Outlook, By Study Design (2016-2026) ($MN)
Table 3 Global Clinical Trials Market Outlook, By Expanded Access (2016-2026) ($MN)
Table 4 Global Clinical Trials Market Outlook, By Interventional (2016-2026) ($MN)
Table 5 Global Clinical Trials Market Outlook, By Observational (2016-2026) ($MN)
Table 6 Global Clinical Trials Market Outlook, By Phase (2016-2026) ($MN)
Table 7 Global Clinical Trials Market Outlook, By Phase I (2016-2026) ($MN)
Table 8 Global Clinical Trials Market Outlook, By Phase II (2016-2026) ($MN)
Table 9 Global Clinical Trials Market Outlook, By Phase III (2016-2026) ($MN)
Table 10 Global Clinical Trials Market Outlook, By Phase IV (2016-2026) ($MN)
Table 11 Global Clinical Trials Market Outlook, By Indication (2016-2026) ($MN)
Table 12 Global Clinical Trials Market Outlook, By Pain management (2016-2026) ($MN)
Table 13 Global Clinical Trials Market Outlook, By Ophthalmology (2016-2026) ($MN)
Table 14 Global Clinical Trials Market Outlook, By Oncology (2016-2026) ($MN)
Table 15 Global Clinical Trials Market Outlook, By Obesity (2016-2026) ($MN)
Table 16 Global Clinical Trials Market Outlook, By Nose (2016-2026) ($MN)
Table 17 Global Clinical Trials Market Outlook, By Musculoskeletal (2016-2026) ($MN)
Table 18 Global Clinical Trials Market Outlook, By Metabolic (2016-2026) ($MN)
Table 19 Global Clinical Trials Market Outlook, By Mental disorders (2016-2026) ($MN)
Table 20 Global Clinical Trials Market Outlook, By Infections (2016-2026) ($MN)
Table 21 Global Clinical Trials Market Outlook, By Genitourinary (2016-2026) ($MN)
Table 22 Global Clinical Trials Market Outlook, By Gastrointestinal (2016-2026) ($MN)
Table 23 Global Clinical Trials Market Outlook, By Ear (2016-2026) ($MN)
Table 24 Global Clinical Trials Market Outlook, By Diabetes (2016-2026) ($MN)
Table 25 Global Clinical Trials Market Outlook, By Dermatology (2016-2026) ($MN)
Table 26 Global Clinical Trials Market Outlook, By CVS (2016-2026) ($MN)
Table 27 Global Clinical Trials Market Outlook, By Congenital (2016-2026) ($MN)
Table 28 Global Clinical Trials Market Outlook, By CNS condition (2016-2026) ($MN)
Table 29 Global Clinical Trials Market Outlook, By Circulatory (2016-2026) ($MN)
Table 30 Global Clinical Trials Market Outlook, By Cardiovascular (2016-2026) ($MN)
Table 31 Global Clinical Trials Market Outlook, By Cancer (2016-2026) ($MN)
Table 32 Global Clinical Trials Market Outlook, By Blood disorders (2016-2026) ($MN)
Table 33 Global Clinical Trials Market Outlook, By Autoimmune (2016-2026) ($MN)
Table 34 Global Clinical Trials Market Outlook, By End User (2016-2026) ($MN)
Table 35 Global Clinical Trials Market Outlook, By Dental Academic (2016-2026) ($MN)
Table 36 Global Clinical Trials Market Outlook, By Dental Hospitals & Clinics (2016-2026) ($MN)
Table 37 Global Clinical Trials Market Outlook, By Dental Institutes (2016-2026) ($MN)
Table 38 Global Clinical Trials Market Outlook, By Research Institutes (2016-2026) ($MN)
Table 39 North America Clinical Trials Market Outlook, By Study Design (2016-2026) ($MN)
Table 40 North America Clinical Trials Market Outlook, By Phase (2016-2026) ($MN)
Table 41 North America Clinical Trials Market Outlook, By Indication (2016-2026) ($MN)
Table 42 North America Clinical Trials Market Outlook, By End User (2016-2026) ($MN)
Table 43 Europe Clinical Trials Market Outlook, By Study Design (2016-2026) ($MN)
Table 44 Europe Clinical Trials Market Outlook, By Phase (2016-2026) ($MN)
Table 45 Europe Clinical Trials Market Outlook, By Indication (2016-2026) ($MN)
Table 46 Europe Clinical Trials Market Outlook, By End User (2016-2026) ($MN)
Table 47 Asia Pacific Clinical Trials Market Outlook, By Study Design (2016-2026) ($MN)
Table 48 Asia Pacific Clinical Trials Market Outlook, By Phase (2016-2026) ($MN)
Table 49 Asia Pacific Clinical Trials Market Outlook, By Indication (2016-2026) ($MN)
Table 50 Asia Pacific Clinical Trials Market Outlook, By End User (2016-2026) ($MN)
Table 51 South America Clinical Trials Market Outlook, By Study Design (2016-2026) ($MN)
Table 52 South America Clinical Trials Market Outlook, By Phase (2016-2026) ($MN)
Table 53 South America Clinical Trials Market Outlook, By Indication (2016-2026) ($MN)
Table 54 South America Clinical Trials Market Outlook, By End User (2016-2026) ($MN)
Table 55 Middle East & Africa Clinical Trials Market Outlook, By Study Design (2016-2026) ($MN)
Table 56 Middle East & Africa Clinical Trials Market Outlook, By Phase (2016-2026) ($MN)
Table 57 Middle East & Africa Clinical Trials Market Outlook, By Indication (2016-2026) ($MN)
Table 58 Middle East & Africa Clinical Trials Market Outlook, By End User (2016-2026) ($MN)